Nursedive logo NurseDive
NurseDive

Nursing practice questions with comprehensive rationales

Start Free

NurseDive Free Nursing Practice Question

A nurse is planning to teach an educational session about chlamydia. Which of the following information should the nurse plan to include?

A. Chlamydia is treated using antiviral medications.

Chlamydia is a bacterial infection, so it is treated with antibiotics, not antiviral medications.

B. Clients can resume intercourse once treatment has started.

Clients should abstain from sexual intercourse until the treatment course is completed to prevent transmission.

C. A chlamydia infection is often asymptomatic in female clients.

Chlamydia infections are often asymptomatic in both males and females, which can lead to undiagnosed and untreated infections. Routine screening is important to detect and treat infections early.

D. Female clients who are at risk for chlamydia should be screened every 2 years.

The recommended frequency for chlamydia screening in female clients at risk is annually, not every 2 years.

This question is an excerpt from Nurse Dive's nursing test bank - RN ati Concept-based assessment level proctored exam. Take the full exam now


Full Explanation

Choice A rationale:

Chlamydia is a bacterial infection, so it is treated with antibiotics, not antiviral medications.

Choice B rationale:

Clients should abstain from sexual intercourse until the treatment course is completed to prevent transmission.

Choice C rationale:

Chlamydia infections are often asymptomatic in both males and females, which can lead to undiagnosed and untreated infections. Routine screening is important to detect and treat infections early.

Choice D rationale:

The recommended frequency for chlamydia screening in female clients at risk is annually, not every 2 years.


Similar Questions

QUESTION

A nurse is providing teaching about lithium to a client who has bipolar disorder. Which of the following information should the nurse include?

A. "Restrict your fluid intake while taking lithium.

Restricting fluid intake is not the primary concern when taking lithium. It's more important to maintain a consistent level of sodium intake.

B. "Double your dose of lithium if you experience blurred vision."

Doubling the dose of lithium without medical supervision can lead to lithium toxicity, which can be life-threatening.

C. "Consume a moderate-sodium diet while taking lithium."

Sodium levels can impact the effectiveness and safety of lithium. Consuming a moderate- sodium diet helps prevent sodium depletion or overload, which can affect lithium levels.

D. "Slurred speech can indicate that your lithium level is low."

Slurred speech is not indicative of low lithium levels. It's important to monitor for signs of lithium toxicity, which include tremors, confusion, and GI symptoms.

Full Explanation

Choice A rationale:

Restricting fluid intake is not the primary concern when taking lithium. It's more important to maintain a consistent level of sodium intake.

Choice B rationale:

Doubling the dose of lithium without medical supervision can lead to lithium toxicity, which can be life-threatening.

Choice C rationale:

Sodium levels can impact the effectiveness and safety of lithium. Consuming a moderate- sodium diet helps prevent sodium depletion or overload, which can affect lithium levels.

Choice D rationale:

Slurred speech is not indicative of low lithium levels. It's important to monitor for signs of lithium toxicity, which include tremors, confusion, and GI symptoms.

QUESTION

A nurse is caring for a client who has Parkinson's disease and a new prescription for pramipexole. The nurse should monitor the client for which of the following findings as an adverse effect of this medication?

A. Diarrhea

Diarrhea is not commonly associated with pramipexole use.

B. Drowsiness

Drowsiness is a common adverse effect of pramipexole and can impair the client's ability to perform tasks that require alertness.

C. Tachypnea

Tachypnea (rapid breathing) is not typically associated with pramipexole use.

D. Bradycardia

Bradycardia (slow heart rate) is not a common adverse effect of pramipexole.

Full Explanation

Choice A rationale:

Diarrhea is not commonly associated with pramipexole use.

Choice B rationale:

Drowsiness is a common adverse effect of pramipexole and can impair the client's ability to perform tasks that require alertness.

Choice C rationale:

Tachypnea (rapid breathing) is not typically associated with pramipexole use.

Choice D rationale:

Bradycardia (slow heart rate) is not a common adverse effect of pramipexole.

QUESTION

A nurse is caring for a client who is at 36 weeks of gestation and experiencing hypertension. Which of the following tests should the nurse use to monitor fetal well-being?

A. Maternal Hgb and Hct

Maternal hemoglobin and hematocrit levels are important indicators of the mother's health but are not direct indicators of fetal well-being.

B. Coombs test

A Coombs test is performed on newborns to assess for hemolytic disease, not to monitor fetal well-being.

C. Biophysical profile

A biophysical profile assesses multiple parameters of fetal well-being, including fetal heart rate, fetal movement, fetal breathing, amniotic fluid volume, and fetal tone.

D. Alpha fetoprotein

An alpha-fetoprotein test is a screening test for neural tube defects and chromosomal abnormalities but is not typically used to monitor fetal well-being in hypertensive pregnancies.

Full Explanation

Choice A rationale:

Maternal hemoglobin and hematocrit levels are important indicators of the mother's health but are not direct indicators of fetal well-being.

Choice B rationale:

A Coombs test is performed on newborns to assess for hemolytic disease, not to monitor fetal well-being.

Choice C rationale:

A biophysical profile assesses multiple parameters of fetal well-being, including fetal heart rate, fetal movement, fetal breathing, amniotic fluid volume, and fetal tone.

Choice D rationale:

An alpha-fetoprotein test is a screening test for neural tube defects and chromosomal abnormalities but is not typically used to monitor fetal well-being in hypertensive pregnancies.